000 | 01194 a2200349 4500 | ||
---|---|---|---|
005 | 20250515182111.0 | ||
264 | 0 | _c20091216 | |
008 | 200912s 0 0 eng d | ||
022 | _a1549-490X | ||
024 | 7 |
_a10.1634/theoncologist.2009-0088 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKim, AeRang | |
245 | 0 | 0 |
_aSorafenib and sunitinib. _h[electronic resource] |
260 |
_bThe oncologist _cAug 2009 |
||
300 |
_a800-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aBenzenesulfonates _xadverse effects |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xadverse effects |
650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
650 | 0 | 4 | _aPhenylurea Compounds |
650 | 0 | 4 |
_aPyridines _xadverse effects |
650 | 0 | 4 |
_aPyrroles _xadverse effects |
650 | 0 | 4 | _aSorafenib |
650 | 0 | 4 | _aSunitinib |
700 | 1 | _aBalis, Frank M | |
700 | 1 | _aWidemann, Brigitte C | |
773 | 0 |
_tThe oncologist _gvol. 14 _gno. 8 _gp. 800-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1634/theoncologist.2009-0088 _zAvailable from publisher's website |
999 |
_c19055859 _d19055859 |